1-7 of 7
Michele Massimino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High BCR-ABL/GUS IS Levels at Diagnosis Are Associated with Unfavorable Responses to Standard Dose Imatinib

Paolo Vigneri, MDPhD, Fabio Stagno, MDPhD, Stefania Stella, PhD, Alessandra Cupri, MD, Stefano Forte, PhD, Michele Massimino, PhD, Agostino Antolino, MD, Clementina Caracciolo, MD, Laura Nocilli, MD, Stefana Impera, MD, Caterina Musolino, Diamante Turri, MD, Mario Russo, MD, Carmela Anna Maria Tomaselli, MD, Michele Rizzo, MD, Maurizio Musso, MD, Fortunato Morabito, MD, Luciano Levato, MD, Livia Manzella, MDPhD, Martin C Mueller, MD, Andreas Hochhaus, MD, Francesco Di Raimondo, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4049.
https://doi.org/10.1182/blood.V126.23.4049.4049
Published: 2015
Journal Articles

High BCR-ABL/GUS IS Levels At Diagnosis Are Associated With Unfavorable Responses To Imatinib

Paolo G Vigneri, MD/PhD, Fabio Stagno, MD, Stefania Stella, PhD, Alessandra Cupri, Stefano Forte, Michele Massimino, PhD, Agostino Antolino, MD, Clementina Caracciolo, Laura Nocilli, Stefana Impera, Caterina Musolino, MD, Diamante Turri, Mario Russo, MD, Carmen Tomaselli, Michele Rizzo, MD, Maurizio Musso, Fortunato Morabito, MD, Luciano Levato, Livia Manzella, MD/PhD, Martin C Muller, MD, Andreas Hochhaus, MD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2013) 122 (21): 1495.
https://doi.org/10.1182/blood.V122.21.1495.1495
Published: 2013
Journal Articles

High BCR-ABL Levels At Diagnosis Are Associated with Unfavorable Responses to Imatinib Mesylate.

Paolo G Vigneri, Fabio Stagno, Stefania Stella, Alessandra Cupri, Stefano Forte, Michele Massimino, Agostino Antolino, MD, Clementina Caracciolo, Laura Nocilli, Stefana Impera, Caterina Musolino, MD, Diamante Turri, Mario Russo, Carmen Tomaselli, Michele Rizzo, Maurizio Musso, Fortunato Morabito, Luciano Levato, Livia Manzella, Martin Mueller, MD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2012) 120 (21): 2790.
https://doi.org/10.1182/blood.V120.21.2790.2790
Published: 2012
Journal Articles

BCR-ABL IS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy.

Paolo Vigneri, MD, PhD, Fabio Stagno, MD, Stefania Stella, PhD, Alessandra Cupri, MD, PhD, Michele Massimino, PhD, Agostino Antolino, MD, Vincenzo Abbadessa, MD, Maura Brugiatelli, MD, Patrizia Guglielmo, MD, Caterina Musolino, MD, Diamante Turri, MD, Mario Russo, MD, Guido Pagnucco, MD, Michele Rizzo, MD, Maurizio Musso, MD, Fortunato Morabito, MD, Luciano Levato, Angelo Messina, MD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2010) 116 (21): 3426.
https://doi.org/10.1182/blood.V116.21.3426.3426
Published: 2010
Journal Articles

Treatment with TKIs Overcomes Imatinib Resistance through the PLCgamma-1 Signaling Pathway In Imatinib Resistant Human CML Cell Lines

Alessandra Romano, Paolo Vigneri, MD, PhD, Chiara Romano, Calogero Vetro, MD, Stefania Stella, PhD, Michele Massimino, PhD, Fabio Stagno, MD, Francesco Di Raimondo, Lance Liotta, Virginia Espina
Journal: Blood
Blood (2010) 116 (21): 4468.
https://doi.org/10.1182/blood.V116.21.4468.4468
Published: 2010
Journal Articles

Sustained Responses and Resistance to Imatinib Mesylate in the First 173 Chronic Myeloid Leukemia Patients Accrued by the SCREEN Multicenter Study: First Interim Report.

Paolo Vigneri, MD, PhD, Fabio Stagno, Stefania Stella, PhD, Alessandra Cupri, MD, Michele Massimino, PhD, Vittorio Del Fabro, MD, Carla Consoli, BD, Pietro Bonomo, MD, Vincenzo Abbadessa, MD, Maura Brugiatelli, MD, Patrizia Guglielmo, MD, Caterina Musolino, MD, Rosanna Scimè€, MD, Mario Russo, MD, Guido Pagnucco, MD, Michele Rizzo, MD, Maurizio Musso, MD, Rosario Giustolisi, MD, Angelo Messina, MD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2009) 114 (22): 4276.
https://doi.org/10.1182/blood.V114.22.4276.4276
Published: 2009
Journal Articles

BCR-ABL Tyrosine Kinase Activity Modulates the Phosphorylation, Localization and Function of Interferon Regulatory Factor 5 (irf-5) in Chronic Myeloid Leukemia (CML) Cells.

Michele Massimino, PhD, Livia Manzella, MD, PhD, Fabio Stagno, Maria Letizia Consoli, BD, Manuela Fallica, BD, Alessandra Aloisi, BD, Francesco Di Raimondo, M.D., Angelo Messina, MD, Paolo Vigneri, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2165.
https://doi.org/10.1182/blood.V114.22.2165.2165
Published: 2009